PDCD1 and cancer: Additionally, Peng Lv et al. developed a type of biotechnological cell membrane nanovesicle expressing PD-1 (PD1-BCMNs) and encapsulating Adv, achieving cancer treatment through immunotherapy checkpoint blockade and oncolytic virus therapy within a single nanoparticle.